Navitas Life Sciences, Resonance Health, Biotelemetry, Inc., are dominating the Global Clinical Trial Imaging Market in 2018

Global Clinical Trial Imaging Market is growing at a substantial CAGR of 6.7% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://www.databridgemarketresearch.com/reports/global-clinical-trial-imaging-market

Global clinical trial imaging market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to growing demand for the clinical trial imaging, booming across healthcare, technological advancements of global clinical trial imaging introduction of novel automated systems. The market has witness developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative monitoring technology in clinical trial imaging.  

For instance, In May 2019, Navitas Life Cycle announces acquisition of KAI Research which strengthens its expertise in pain, diabetes, infectious diseases and mental health and intends to create an enterprise to deliver and initiate trial outcomes.

Navitas Life Sciences dominated global clinical trial imaging market.The other key players existing in the market includes BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc, Radiant Sage LLC, Lyscaut Medical Imaging Company, Quotient Sciences, worldcare Clinical, Navitas Life Sciences, Cardiovascular Imaging Technologies, Intrinsic Imaging, Image Core Lab, ERT Clinical, Perspectum Diagnostics, Anagram 4 clinical trials, Parexel International Corporation among others.

Navitas Life Sciences

Navitas Life Sciences headquartered in New Jersey, U.S. The company focuses on providing clinical, regulatory and safety solutions and services. The company has wide range of services category such as clinical, regulatory, safety, consulting, technology and nets. The company has presence in North America, Europe, Asia and South America. The company is continuously engaged in strategic relationship to enhance the product and service of the clinical trial imaging such as,

  • In February 2019, Navitas Life Cycle declared acquisition of DataCeutics Inc. which leads to the growth of Clinical business as well as global clinical market. Dataceutics strengthens the company in its high end biostatics, data management and statical programming which is very beneficial for the company.

Resonance Health

Resonance Health headquartered in Burswood, Australia was founded in 2000. The company is engaged in offering a wide range of product portfolio for healthcare sectors around the world. The company has wide range of product category such as FerriScan MRI Measurement of Liver Iron Concentration, Cardiac T2 with FerriScan, HepaFat-Scan MRI Measurement of Liver Fat, Bone Marrow R2-MRI and Quality Assured Service Delivery. The company has presence in North America, Europe, Asia-Pacific, South America and Middle East and Africa The company is continuously engaged in strategic relationship to enhance the product and service of the clinical trial imaging such as,

  • In January 2019, Resonance Health announced that they have entered into an agreement with EnvoyAI to distribute its FerriSmart product in the U.S. market, the product have received FDA regulatory clearance. After this agreement the company has expanded their business in the U.S. market.

The company has subsidiary such as Resonance Health Analysis Services Pty Limited (Australia), IVB Holdings Pty Ltd (Australia), Resonance USA Inc (U.S.).

BIOTELEMETRY, INC.

Biotelemetry, Inc. headquartered in Pennsylvania, U.S. The company focus on delivery of health information in order to improve quality of life at affordable cost of care. Biotelemetry, Inc has multiple segments such as Healthcare, Research, Other, in this Healthcare is the market focused segment. The company has presence in the U.S. and Europe The company has wide range of services portfolio such as heart monitoring, clinical research, global partnerships, health management, in this market focused portfolio is clinical research.

The company has subsidiary such as CardioNet, Inc. (U.S.), VirtualScopics, Inc. (U.S.), Telcare (U.S.), BioTelemetry Research (U.S.), Cardiocore, LLC (U.S.) and others.